FOXM1 and lung adenocarcinoma: Among the remaining factors, we selected FOXM1 for further analysis (Fig. 3C), with TCGA data indicating that FOXM1 is highly expressed in lung adenocarcinoma (Fig. 3D) and patients with a high expression have a poor prognosis (Fig. 3E).